Traders Buy UnitedHealth Group (UNH) on Weakness

Investors bought shares of UnitedHealth Group Inc (NYSE:UNH) on weakness during trading hours on Wednesday. $148.09 million flowed into the stock on the tick-up and $99.38 million flowed out of the stock on the tick-down, for a money net flow of $48.71 million into the stock. Of all equities tracked, UnitedHealth Group had the 23rd highest net in-flow for the day. UnitedHealth Group traded down ($1.68) for the day and closed at $224.20

UNH has been the subject of several analyst reports. Goldman Sachs Group initiated coverage on UnitedHealth Group in a report on Wednesday, January 3rd. They issued a “buy” rating and a $269.00 price target for the company. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, September 26th. Morgan Stanley boosted their price objective on shares of UnitedHealth Group from $215.00 to $235.00 and gave the company an “overweight” rating in a research note on Wednesday, October 18th. ValuEngine cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 5th. Finally, Leerink Swann reissued a “buy” rating and set a $240.00 price objective (up from $225.00) on shares of UnitedHealth Group in a research note on Wednesday, October 18th. Three investment analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $226.74.

The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70. The stock has a market capitalization of $216,770.00, a PE ratio of 25.48, a price-to-earnings-growth ratio of 1.57 and a beta of 0.66.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The firm had revenue of $50.32 billion during the quarter, compared to analysts’ expectations of $50.38 billion. During the same period in the prior year, the company earned $2.17 EPS. The firm’s revenue was up 8.7% on a year-over-year basis. analysts anticipate that UnitedHealth Group Inc will post 9.99 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Friday, December 1st were given a dividend of $0.75 per share. The ex-dividend date was Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a yield of 1.34%. UnitedHealth Group’s dividend payout ratio (DPR) is 34.09%.

In related news, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the completion of the sale, the director now directly owns 61,137 shares of the company’s stock, valued at approximately $13,652,503.47. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Thomas E. Roos sold 975 shares of the company’s stock in a transaction on Thursday, October 19th. The stock was sold at an average price of $205.47, for a total transaction of $200,333.25. Following the sale, the insider now directly owns 24,630 shares of the company’s stock, valued at $5,060,726.10. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 34,630 shares of company stock valued at $7,669,416. 0.89% of the stock is owned by corporate insiders.

A number of institutional investors have recently made changes to their positions in the stock. Pure Financial Advisors Inc. purchased a new position in UnitedHealth Group in the 4th quarter valued at about $219,000. White Lighthouse Investment Management Inc. purchased a new position in UnitedHealth Group in the 4th quarter valued at about $295,000. Hutchens Investment Management Inc boosted its position in UnitedHealth Group by 8.2% in the 4th quarter. Hutchens Investment Management Inc now owns 8,144 shares of the healthcare conglomerate’s stock valued at $1,795,000 after buying an additional 619 shares during the last quarter. Oak Point Wealth Management purchased a new position in UnitedHealth Group in the 4th quarter valued at about $1,426,000. Finally, Abner Herrman & Brock LLC boosted its position in UnitedHealth Group by 8.7% in the 4th quarter. Abner Herrman & Brock LLC now owns 33,428 shares of the healthcare conglomerate’s stock valued at $7,370,000 after buying an additional 2,669 shares during the last quarter. 86.01% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: This news story was posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The correct version of this news story can be read at https://www.com-unik.info/2018/01/10/traders-buy-unitedhealth-group-unh-on-weakness.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

What are top analysts saying about UnitedHealth Group? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for UnitedHealth Group and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit